- Home
- Innovation
Innovation
What are cataracts?
Cataracts are the most common cause of vision loss worldwide. Luckily a routine surgical procedure can have you viewing the world in crisp, bright color again. Here’s what to know about cataract symptoms and removal.
6 ways Johnson & Johnson is using AI to help advance healthcare
Artificial intelligence is revolutionizing healthcare—from improving surgical training and procedures to equipping healthcare providers with insights and personalizing care for patients around the world. See how the company is harnessing its extraordinary power.
These Johnson & Johnson leaders are breaking new ground in healthcare
Kimberly Lounds Foster and Carmen Canovas Vidal are part of a new wave of innovators bringing their expertise in STEM into the heart of healthcare.
What are alloantibodies?
Learn how Johnson & Johnson is investigating a therapy for two alloantibody-driven diseases that can affect the lives of developing fetuses and newborn babies.
5 things we now know about plaque psoriasis
Plaque psoriasis is the most prevalent form of psoriasis, affecting millions worldwide. Johnson & Johnson is focused on developing novel therapies for chronic dermatologic diseases to address the unmet need that still exists.
Getting in front of cancer
Every year, roughly 2 million people in the U.S. are newly diagnosed with cancer. But new scientific breakthroughs—including ones made at Johnson & Johnson—have dramatically changed the prognosis of many of these patients.
6 things to know now about colorectal cancer
Colorectal cancer is now the leading cause of U.S. cancer deaths among people under 50, and rates of the disease are rising globally, too. For Colorectal Cancer Awareness Month, find out how to protect yourself—no matter your age.
“My company makes the medication that helped me fight multiple myeloma”
Paul Reidy, a Johnson & Johnson warehouse technician in Ireland, never imagined that an oncology therapy made at the facility where he works would help save his life.
5 things we now know about atrial fibrillation
More than 50 million people worldwide are affected by this common type of heart arrhythmia. Learn the facts behind this heart condition, plus one patient’s diagnosis story.
Shockwave IVL: Inside the development of a game-changing technology to treat coronary and peripheral artery disease
Johnson & Johnson’s Patrick Stephens explains how innovative technology using ultrasonic acoustic pressure waves has made the treatment of certain types of cardiovascular disease easier for doctors and safer for patients.